FDA says Shifamed’s Myra Vision can begin glaucoma implant study
August 12, 2025
Myra Vision announced today that it received FDA investigational device exemption (IDE) approval for its Calibreye system
Myra Vision announced today that it received FDA investigational device exemption (IDE) approval for its Calibreye system
Renata Medical announced today that CMS granted a New Technology Add-on Payment (NTAP) for its Minima stent system.